(Q37842431)

24 August 2017

1 reference

title

Excessive daytime sleepiness in patients with Parkinson's disease (English)

1 reference

excessive daytime sleepiness

24 August 2017

1 reference

1 reference

4

K Ray Chaudhuri

1 reference

24 August 2017

Bettina Knie

1

1 reference

24 August 2017

M Tanya Mitra

series ordinal

2

1 reference

24 August 2017

Kartik Logishetty

series ordinal

3

1 reference

24 August 2017

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

3

1 reference

24 August 2017

203-212

1 reference

https://scigraph.springernature.com/pub.10.2165/11539720-000000000-00000

24 August 2017

0 references

cites work

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Nighttime sleep problems and daytime sleepiness in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep issues in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness and subsequent development of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Hypocretin (orexin) cell loss in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Daytime sleepiness and other sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

FAST TRACK: daytime sleepiness in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleepiness in Parkinson's disease: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Parkinson's disease and sleepiness: an integral part of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness in de novo and treated Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Correlates of excessive daytime sleepiness in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

The sleep switch: hypothalamic control of sleep and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Hypocretin (orexin) loss in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Low levels of ventricular CSF orexin/hypocretin in advanced PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Predictors and course of health-related quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Nocturnal symptom complex in PD and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Pramipexole-induced somnolence and episodes of daytime sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Non-ergot dopamine agonist-induced sleep attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Snoring and excessive daytime sleepiness in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Narcolepsy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

A comprehensive model of health-related quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Driving with distraction in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep attacks (sleep episodes) with pergolide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep disorders and sleep effect in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Fatigue in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Effects of dopaminergic treatment on bladder function in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

A community-based study of sleep disorders in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Approved and investigational uses of modafinil : an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sleep disturbances in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Excessive daytime sleepiness and unintended sleep in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539720-000000000-00000

Dopaminergic role in stimulant-induced wakefulness.

21 January 2018

1 reference

12 December 2020

Preprohypocretin polymorphisms in Parkinson disease patients reporting "sleep attacks".

1 reference

12 December 2020

Sleep attacks and Parkinson's disease treatment

1 reference

12 December 2020

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

12 December 2020

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

1 reference

12 December 2020

Core body temperature and sleep of older female insomniacs before and after passive body heating.

1 reference

12 December 2020

Effects of passive body heating on the sleep of older female insomniacs

1 reference

12 December 2020

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial

1 reference

12 December 2020

Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole

1 reference

12 December 2020

A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy

1 reference

12 December 2020

Complications of disease and therapy: a comparison of younger and older patients with Parkinson's disease

1 reference

12 December 2020

A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy.

1 reference

12 December 2020

Daytime sleepiness and alertness in patients with Parkinson disease.

1 reference

12 December 2020

L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/11539720-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

0 references

1 reference